"
Team:Tokyo Tech/Safety
From 2011.igem.org
| (10 intermediate revisions not shown) | |||
| Line 34: | Line 34: | ||
list-style: none; | list-style: none; | ||
float: left; | float: left; | ||
| - | height: | + | height: 30px; |
width: 945px; | width: 945px; | ||
} | } | ||
| Line 43: | Line 43: | ||
position:relative; | position:relative; | ||
padding: 2px 15px 0 0; | padding: 2px 15px 0 0; | ||
| - | |||
| - | |||
| - | |||
| - | |||
} | } | ||
| Line 55: | Line 51: | ||
display: none; | display: none; | ||
position: absolute; | position: absolute; | ||
| - | font-size: | + | font-size: 16px; |
opacity: 0.8; | opacity: 0.8; | ||
list-style: none; | list-style: none; | ||
| Line 79: | Line 75: | ||
background-color: #EFEBEC; | background-color: #EFEBEC; | ||
color: #000000; | color: #000000; | ||
| + | font-size: 13px; | ||
} | } | ||
| Line 86: | Line 83: | ||
left: 0; | left: 0; | ||
clear: both; | clear: both; | ||
| - | height: | + | height: 190px; |
} | } | ||
.main | .main | ||
| Line 111: | Line 108: | ||
} | } | ||
| - | + | h2 | |
{ | { | ||
text-indent: 1em; | text-indent: 1em; | ||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
} | } | ||
| Line 124: | Line 116: | ||
{ | { | ||
text-indent: 2em; | text-indent: 2em; | ||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
} | } | ||
| Line 134: | Line 121: | ||
{ | { | ||
text-indent: 3em; | text-indent: 3em; | ||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
} | } | ||
| Line 166: | Line 148: | ||
p | p | ||
{ | { | ||
| - | text-indent: | + | text-indent: 2em; |
} | } | ||
| Line 214: | Line 196: | ||
} | } | ||
} | } | ||
| + | |||
| + | function getElementsByClass() { | ||
| + | var classElements = new Array(); | ||
| + | var allElements = document.getElementsByTagName("*"); | ||
| + | for (i = 0 ; i < allElements.length; i++) { | ||
| + | if (allElements[i].className == 'firstHeading') { | ||
| + | allElements[i].style.display = 'none'; | ||
| + | // window.alert('発見。'); | ||
| + | } | ||
| + | } | ||
| + | } | ||
| - | + | window.onload = function() { | |
| + | getElementsByClass(); | ||
var menu = window.document.getElementById('TopMenu'); | var menu = window.document.getElementById('TopMenu'); | ||
if(menu==null) | if(menu==null) | ||
| Line 245: | Line 239: | ||
</head> | </head> | ||
<body> | <body> | ||
| - | |||
<!-- top box --> | <!-- top box --> | ||
<div class="top"> | <div class="top"> | ||
| - | < | + | <object classid="clsid:D27CDB6E-AE6D-11cf-96B8-444553540000" codebase="http://download.macromedia.com/pub/shockwave/cabs/flash/swflash.cab#version=6,0,0,0" width="965" height="150" id="Yourfilename" align=""> |
| - | < | + | <param name="movie" value="https://static.igem.org/mediawiki/2011/4/4d/Header.swf"> |
| + | <param name="quality" value="high"> | ||
| + | <param name="bgcolor" value="#FFFFFF"> | ||
| + | <embed src="https://static.igem.org/mediawiki/2011/4/4d/Header.swf" quality="high" bgcolor="#FFFFFF" width="965" height="150" name="Yourfilename" align="" type="application/x-shockwave-flash" pluginspage="http://www.macromedia.com/go/getflashplayer"> | ||
| + | </embed> | ||
| + | </object> | ||
<!-- list of top menu --> | <!-- list of top menu --> | ||
<div id="navigation"> | <div id="navigation"> | ||
| Line 256: | Line 254: | ||
<li id="menu_Project"> | <li id="menu_Project"> | ||
| - | + | Project | |
<ul> | <ul> | ||
| - | <li><a href="https://2011.igem.org/Team:Tokyo_Tech/Projects/RPS-game/index.htm">RPS- | + | <li><a href="https://2011.igem.org/Team:Tokyo_Tech/Projects/RPS-game/index.htm">RPS-Game</a></li> |
| - | <li><a href="https://2011.igem.org/Team:Tokyo_Tech/Projects/making-rain/index.htm"> | + | <li><a href="https://2011.igem.org/Team:Tokyo_Tech/Projects/making-rain/index.htm">Make it Rain</a></li> |
| - | <li><a href="https://2011.igem.org/Team:Tokyo_Tech/Projects/Urea-cooler/index.htm"> | + | <li><a href="https://2011.igem.org/Team:Tokyo_Tech/Projects/Urea-cooler/index.htm">Urea Coolers</a></li> |
</ul> | </ul> | ||
</li> | </li> | ||
| Line 269: | Line 267: | ||
Modeling | Modeling | ||
<ul> | <ul> | ||
| - | <li><a href="https://2011.igem.org/Team:Tokyo_Tech/Modeling/RPS-game/RPS-game">RPS- | + | <li><a href="https://2011.igem.org/Team:Tokyo_Tech/Modeling/RPS-game/RPS-game">RPS-Game</li> |
| - | <li><a href="https://2011.igem.org/Team:Tokyo_Tech/Modeling/Urea-cooler/urea-cooler"> | + | <li><a href="https://2011.igem.org/Team:Tokyo_Tech/Modeling/Urea-cooler/urea-cooler">Urea Coolers</li> |
</ul> | </ul> | ||
</li> | </li> | ||
| - | <li id=" | + | <li id="menu_Human Practice"><a href="https://2011.igem.org/Team:Tokyo_Tech/HumanPractice.htm">Human Practice</a></li> |
<li id="menu_Sitemap"><a href="https://2011.igem.org/Team:Tokyo_Tech/sitemap.htm">Sitemap</a></li> | <li id="menu_Sitemap"><a href="https://2011.igem.org/Team:Tokyo_Tech/sitemap.htm">Sitemap</a></li> | ||
<li id="menu_Extra"> | <li id="menu_Extra"> | ||
| - | + | More | |
| - | <ul> | + | <ul style="width:210px;"> |
<li><a href="https://2011.igem.org/Team:Tokyo_Tech/Safety">Safety</a></li> | <li><a href="https://2011.igem.org/Team:Tokyo_Tech/Safety">Safety</a></li> | ||
<li><a href="https://2011.igem.org/Team:Tokyo_Tech/Attribution_and_Contributions.htm">Attribution and Contributions</a></li> | <li><a href="https://2011.igem.org/Team:Tokyo_Tech/Attribution_and_Contributions.htm">Attribution and Contributions</a></li> | ||
<li><a href="https://2011.igem.org/Team:Tokyo_Tech/notebook">NoteBook</a></li> | <li><a href="https://2011.igem.org/Team:Tokyo_Tech/notebook">NoteBook</a></li> | ||
<li><a href="https://2011.igem.org/Team:Tokyo_Tech/team">Team</a></li> | <li><a href="https://2011.igem.org/Team:Tokyo_Tech/team">Team</a></li> | ||
| - | <li><a href="https://2011.igem.org/Team:Tokyo_Tech/Sponsers.htm"> | + | <li><a href="https://2011.igem.org/Team:Tokyo_Tech/Sponsers.htm">Sponsors</a></li> |
<li><a href="https://2011.igem.org/Team:Tokyo_Tech/Collaboration.htm">Collaboration</a></li> | <li><a href="https://2011.igem.org/Team:Tokyo_Tech/Collaboration.htm">Collaboration</a></li> | ||
</ul> | </ul> | ||
| Line 303: | Line 301: | ||
<!-- main contents --> | <!-- main contents --> | ||
<div class="_main"> | <div class="_main"> | ||
| - | <!-- ############ | + | <!-- ############ Write main contents here ############### --> |
<!-- page title --> | <!-- page title --> | ||
<h1> Safety </h1> | <h1> Safety </h1> | ||
| - | + | ||
<p> | <p> | ||
For iGEM 2011 teams are asked to detail how they approached any issues of biological safety | For iGEM 2011 teams are asked to detail how they approached any issues of biological safety | ||
| - | associated with their projects. Specifically, teams should consider the following | + | associated with their projects. Specifically, teams should consider the following questions: |
| - | + | ||
</p> | </p> | ||
| Line 322: | Line 319: | ||
</b> | </b> | ||
</p> | </p> | ||
| - | <p> | + | <p style="margin-left:30px;"> |
A1. No, our project ideas do not raise any safety issue in terms of researcher safety, | A1. No, our project ideas do not raise any safety issue in terms of researcher safety, | ||
public safety or environmental safety. All the experiments are carried out in the lab, | public safety or environmental safety. All the experiments are carried out in the lab, | ||
| Line 337: | Line 334: | ||
</b> | </b> | ||
</p> | </p> | ||
| - | <p> | + | <p style="margin-left:30px;"> |
A2.No, none of the BioBricks parts (or devices) that we have made this year raises any safety | A2.No, none of the BioBricks parts (or devices) that we have made this year raises any safety | ||
issue, they are all BL1 and BL2. | issue, they are all BL1 and BL2. | ||
| Line 349: | Line 346: | ||
</b> | </b> | ||
</p> | </p> | ||
| - | <p> | + | <p style="margin-left:30px;"> |
A3. Yes there is. The biosafety committee of our organization accepted part of our applications. | A3. Yes there is. The biosafety committee of our organization accepted part of our applications. | ||
The other part of the applications is going to be evaluated. After all of our applications have been accepted, | The other part of the applications is going to be evaluated. After all of our applications have been accepted, | ||
| Line 363: | Line 360: | ||
</b> | </b> | ||
</p> | </p> | ||
| - | <p> | + | <p style="margin-left:30px;"> |
A4. We think is a good idea to use review sheets to have information about the parts. These review sheets can be made in collaboration with the local biosafety group. | A4. We think is a good idea to use review sheets to have information about the parts. These review sheets can be made in collaboration with the local biosafety group. | ||
</p> | </p> | ||
| - | + | <p> | |
| + | <b> | ||
| + | Q5. Isn't isoprene you used in the project harmful to human or <span class="name">E. coli</span> ? | ||
| + | </b> | ||
| + | </p> | ||
| + | <p style="margin-left:30px;"> | ||
| + | A5. No, isoprene is not harmful to <span class="name">E. coli</span> or human unless being inhaled over 0.19 mg/L(59 mg/kg).The amount of | ||
| + | isoprene produced by our <span class="name">E. coli</span> is 0.04 mg/batch-L and it is too small to have influence on human and <span class="name">E. coli</span>. | ||
| + | There is some reports that isoperene might have chance to be carcinogenic, but the chance is as higher as | ||
| + | that of coffeic acid. | ||
| + | </p> | ||
| + | |||
<!-- ############ End of main contents ############ --> | <!-- ############ End of main contents ############ --> | ||
Latest revision as of 13:26, 28 October 2011
Safety
For iGEM 2011 teams are asked to detail how they approached any issues of biological safety associated with their projects. Specifically, teams should consider the following questions:
Q1. Would any of your project ideas raise safety issues in terms of researcher safety, public safety or environmental safety ?
A1. No, our project ideas do not raise any safety issue in terms of researcher safety, public safety or environmental safety. All the experiments are carried out in the lab, they are safe for the researcher and the environment, and they do not have any impact outside the lab.
Q2. Do any of the new BioBrick parts (or devices) that you made this year raise any safety issues? If yes,did you document these issues in the Registry? how did you manage to handle the safety issue? how could other teams learn from your experience?
A2.No, none of the BioBricks parts (or devices) that we have made this year raises any safety issue, they are all BL1 and BL2.
Q3. Is there a local biosafety group, committee, or review board at your institution? If yes, what does your local biosafety group think about your project?
A3. Yes there is. The biosafety committee of our organization accepted part of our applications. The other part of the applications is going to be evaluated. After all of our applications have been accepted, we will start wet experiments.
Q4. Do you have any other ideas how to deal with safety issues that could be useful for future iGEM competitions? How could parts, devices and systems be made even safer through biosafety engineering?
A4. We think is a good idea to use review sheets to have information about the parts. These review sheets can be made in collaboration with the local biosafety group.
Q5. Isn't isoprene you used in the project harmful to human or E. coli ?
A5. No, isoprene is not harmful to E. coli or human unless being inhaled over 0.19 mg/L(59 mg/kg).The amount of isoprene produced by our E. coli is 0.04 mg/batch-L and it is too small to have influence on human and E. coli. There is some reports that isoperene might have chance to be carcinogenic, but the chance is as higher as that of coffeic acid.
